Randomized Phase III Trial of Pembrolizumab vs. Pembrolizumab/Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Platinum Refractory Disease
Protocol #A092205
Trial Phase:Phase III
Principal Investigator:Alesi, Erin
Cancer Type
- Eye and Orbit
- Larynx
- Lip
- Oral Cavity and Pharynx
- Stony Point
- Virginia Commonwealth University
Get more detailed information at ClinicalTrials.gov
- Protocol Type Treatment
-
Research Study Team
Carrie Donovan, RN
Phone: +1 804-628-3836
Email Study Contact
Click "I'm Interested" to get started. If you have questions, call our study contact.
I'm InterestedHave a question? We're here to help.
Email us or call us with your request.
Send an Email ยป (804) 628-6430